# Clinical Efficacy and Safety of Nivolumab: Results of a <u>M</u> ulticenter, Op <u>e</u> n-label, Single-a <u>r</u> m, Japanese Phase II study in Mal <u>i</u> gnant Pleural Meso <u>t</u> helioma (MERIT)

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/clinical-efficacy-and-safety-of-nivolumab-results-of-a-u-m-u-ulticenter-op-u-e-u/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Morihito Okada,Takashi Kijima,Keisuke Aoe,Terufumi Kato,Nobukazu Fujimoto,Kazuhiko Nakagawa,Yuichiro Takeda,Toyoaki Hida,Kuninobu Kanai,Fumio Imamura,Satoshi Oizumi,Toshiaki Takahashi,Mitsuhiro Takenoyama,Hiroshi Tanaka,Jun Hirano,Yoshinobu Namba,Yuichiro Ohe |
| Citations | 237 |
| DOI | 10.1158/1078-0432.ccr-19-0103 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2948619068 |
| PMID | 31164373 |
| Type | article |
| Year | 2019 |

## Paper authors

- [Nobukazu Fujimoto](https://scholariq.org/researchers/nobukazu-fujimoto/)

## Paper journal

- [Clinical Cancer Research](https://scholariq.org/journals/clinical-cancer-research/)

## Paper primary topic

- [Occupational and environmental lung diseases](https://scholariq.org/topics/occupational-and-environmental-lung-diseases/)

## Paper topics

- [Occupational and environmental lung diseases](https://scholariq.org/topics/occupational-and-environmental-lung-diseases/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Pleural and Pulmonary Diseases](https://scholariq.org/topics/pleural-and-pulmonary-diseases/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.